Form 8-K IDEAYA Biosciences, Inc. For: Dec 04

Go back to Form 8-K IDEAYA Biosciences, Inc. For: Dec 04

GSK terminates collaboration agreement with IDEAYA Biosciences

December 5, 2025 4:26 PM EST

GlaxoSmithKline notified IDEAYA Biosciences Inc. (NASDAQ: IDYA) on December 4, 2024, of its decision to terminate their collaboration, option and license agreement originally signed on June 15, 2020.

The termination will become effective 90 days after GSK's written notice. During this transition period, GSK will transfer two clinical... More